SHARE

AsianScientist (Oct. 3, 2016) – This year, five scientists from Asia Pacific institutions or countries of origin have been chosen by the Intellectual Property and Science business of Thomson Reuters as its 2016 Citation Laureates.

Since it began in 2002, the annual Citation Laureates study has predicted 39 Nobel Prize winners to date. The study mines scientific research citations within the Web of Science database to identify the most influential researchers in chemistry, physics, physiology or medicine, and economics who are likely winners of the Nobel Prize in current or future years.

For the second consecutive year, science enthusiasts were invited to weigh in with their own Nobel Prize predictions by participating in the People’s Choice survey for Nobel Prizes.

“Highly-cited papers turn out to be one of the most reliable indicators of world-class research, and provides a glimpse at what research stands the best chance at being recognized with a Nobel Prize,” said Ms. Jessica Turner, global head of government and academia, Intellectual Property and Science, Thomson Reuters.

——

This year’s honorees are:

1. Tasuku Honjo
   Visiting Professor, Kyoto University
   Kyoto, Japan

   For elucidating programmed cell death-1 (PD-1) and its pathway, which has advanced cancer immunotherapy.




2. Dennis Lo Yuk-Ming
   Li Ka Shing Professor of Medicine and of Chemical Pathology, and Director of the Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong
   Hong Kong, China

   For detecting cell-free fetal DNA in maternal plasma, a revolution in noninvasive prenatal testing.




3. Hiroshi Maeda
   Professor, Institute of Drug Delivery Science, Sojo University, and Professor Emeritus, Kumamoto University School of Medicine
   Kumamoto, Japan

   and
   
   

4. Yasuhiro Matsumura
   Director, Division of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Japan
   Tokyo, Japan

   For discovering the enhanced permeability and retention (EPR) effect of macromolecular drugs, a key finding for cancer therapeutics.




5. Zhang Feng
   W. M. Keck Career Development Professor of Biomedical Engineering, Massachusetts Institute of Technology, USA
   Core Member, Broad Institute, Cambridge, MA, USA

   For application of CRISPR-cas9 gene editing in mouse and human cells.

———

Source: Thomson Reuters; Photo: Shutterstock.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.